Use of VAP-1 Inhibitors for Treating Fibrotic Conditions

The present invention relates to inhibitors of VAP-1 and their use as medicaments in treating fibrotic conditions. Furthermore, the present invention relates to a method of diagnosing a fibrotic condition on the basis of elevated level of soluble VAP-1 or SSAO activity in a bodily fluid, and to a kit for use in said diagnostic method.

Patents:
WO 2,011,029,996   [MORE INFO]

Inventor(s): WESTON CHRISTOPHER [GB]; CLARIDGE LEE CHARLES [GB]; ADAMS DAVID [GB]; SMITH DAVID [FI]; WESTERLUND NINA [FI]; PIHLAVISTO MARJO [

Type of Offer: Sale



« More Medical Patents

---